# Intrauterine Device Insertion Pain Management

> **NCT06951191** · PHASE4 · TERMINATED · sponsor: **University of Missouri-Columbia** · enrollment: 1 (actual)

## Conditions studied

- IUD Insertion Pain
- IUD Insertion

## Interventions

- **DRUG:** Benzocaine 20%
- **DRUG:** Lidocaine 2%
- **OTHER:** Sham injection
- **DRUG:** Saline 0.9%

## Key facts

- **NCT ID:** NCT06951191
- **Lead sponsor:** University of Missouri-Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2025-06-23
- **Primary completion:** 2026-04-15
- **Final completion:** 2026-04-15
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Inadequate recruitment
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06951191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06951191, "Intrauterine Device Insertion Pain Management". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06951191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*